Cannabis Science Inc. Announces Progress in Bringing the First Cannabis Based Medicine to Market

Cannabis Science Inc. announces that it is finalizing agreements with suppliers, manufactures, and research institutions that it expects will close within days and weeks to come. Once these agreements are closed they will be announced along with details on how CBIS will bring its first Cannabis based pharmaceutical products to market.

“We have worked hard to get to this point and look forward to sharing the details with our shareholders in a timely fashion, and we appreciate their continued support.”

“We have worked hard to get to this point and look forward to sharing the details with our shareholders in a timely fashion, and we appreciate their continued support” stated Dr. Robert Melamede, President & CEO.

Cannabis Science is in negotiations with several companies in the US and internationally to contract or license its cannabis based formulations for development, certain rights to manufacturing processes, and sales in each prospective jurisdiction and or country.

A stunning report concludes that researchers often ask statisticians to make "inappropriate requests." Not accidental requests for incorrect statistical analyses; but unscrupulous data manipulation or even fraud.